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Abstract  
Background:  Studies with single baseline measurements of cognitive function consistently reveal 
inverse relationships with mortality risk.  The impact of change in functioning, particularly from 
early in the life course, which may offer additional insights into causality, has not, to the best of our 
knowledge, been tested.   
Aims: To examine the association of change in cognition between late adolescence and middle-age 
with cause-specific mortality using data from a prospective cohort study.   
Methods:  The analytic sample consisted of 4289 US male former military personnel who were 
administered the Army General Technical Test in early adulthood (mean age 20.4 yr.) and again in 
middle-age (mean age 38.3 yr.).   
Results: A 15 year period of mortality surveillance subsequent to the second phase of cognitive 
testing gave rise to 237 deaths.  Following adjustment for age, a ten unit increase in cognitive 
function was related to a reduced risk of death from all-causes (hazard ratio; 95% confidence 
interval:  0.84; 0.75, 0.93) and cardiovascular disease (0.78; 0.64, 0.95) but not from all cancers 
(1.14; 0.88, 1.47) nor injury (1.02; 0.81, 1.29).  Adjustment for markers of socioeconomic status in 
middle-age resulted in marked attenuation in the magnitude of these associations and statistical 
significance at conventional levels was lost in all analyses.  
Conclusions: Increases in cognitive function earlier in the life course were associated with lower 
mortality risk, and these effects were mediated by socioeconomic status in the present study.  
 
Key words: cognitive function, cohort, mortality  
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What is already known on this subject? 
• Studies with single baseline measurements of cognitive function consistently reveal inverse 
relationships with mortality risk.   
 
What does this study add? 
• The impact of change in cognitive function, particularly from early in the life course, which may 
offer additional insights into causality, has not been examined.   
• Increases in cognitive function earlier in the life course appear to be associated with lower risk of 
death, most notably for total and cardiovascular disease mortality. 








Findings from numerous prospective cohort studies indicate that scores from standard tests of 
cognitive function administered at a single point in the life course are related to total mortality risk, 
such that higher-scoring people typically have lower death rates. 1-5  Inverse relationships have also 
been observed for cognition and selected chronic diseases, including coronary heart disease6,7 and 
stroke,8,9 but rarely cancer10,11  The strongest effects are apparent for unintentional and intentional 
injury.12-15  As informative as these findings have been, they inevitably have methodological 
weaknesses that hamper data interpretation.  Being based exclusively on observational data, an 
obvious and perennial concern is the impact of confounding, such that cognitive ability is related to 
an array of risk factors for chronic disease and injury, most obviously socioeconomic position and 
somatic illness, and it could be some or all of these covariates, rather than lower cognitive function 
per se, that generate the relation with future death.  Whereas the standard statistical adjustments are 
often made for covariates, some may be unmeasured or, in the case of morbidity, selected diseases 
may be hidden at study entry.   
 
In principle, confounding could be resolved by the use of randomised controlled trials,16 but these 
are probably logistically prohibitive in the context of mortality and chronic diseases, many of which 
have extended induction periods.  Additionally, the interventions that might be effective in raising 
cognitive ability, or slowing decline, are currently unclear.17  An alternative approach is to simulate 
a trial within the context of an observational study.18-21  Although also not free from confounding, 
if, in a cohort study with repeat assessments of cognition, the lowest risk of later mortality is 
apparent in people with gains in cognitive functioning, this would provide stronger evidence of 
causality than studies with a single baseline measurement.  A further important advantage of this 
repeat assessment of cognition is that, in keeping with many other potential determinants of 
mortality, such as health behaviours and biomedical risk markers, cognitive function is time-
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varying.22,23  Serial measurements would therefore result in an enhanced characterisation of the 
exposure.   
 
Few studies are sufficiently large, long running, and well-characterised enough to have the capacity 
to examine the link between change in cognitive function and mortality risk.  Those that have these 
qualities have typically sampled older aged people (>=70 years) where a drop in cognitive ability 
has been shown to be related to an elevation in death rate.24,25  Using data from the Vietnam 
Experience Study, we have previously shown a relationship between higher cognitive function in 
early adulthood and lower mortality risk.26  The same test of cognitive function was re-administered 
in middle-age, so allowing us to also explore the association of change in cognitive ability with later 
mortality risk in this sample.  To the best of our knowledge, this is the first study to examine 
whether cognitive change from as early as adolescence to middle-age is associated with subsequent 
mortality.   
 
Methods 
The Vietnam Experience Study has been described in detail elsewhere.26-30  In brief, 18,313 male 
US military personnel who entered the service between 1965 and 1971 qualified for inclusion in 
this cohort study (mean age 20.4, SD 1.7).  Information pertaining to military rank, ethnicity, and 
cognitive ability were extracted from military archives.  Based on attained military rank, the 
monthly income of the army personnel using 1964 pay scales was derived.  The ethnic origin of the 
study members was classified as ‘white’, ‘black’, or ‘other’ (Hispanics, Asians, Pacific Islanders, 
American Indians, and Alaskan Natives).  To give guidance as to the potential rank of the soldier, 
the Army General Technical Test, a general cognitive aptitude test, was routinely administered.  
Scores from this test correlate moderately highly with well-established devices such as the 
Wechsler Adult Intelligence Scale.31     
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Data collection in middle-age  
The 17,867 men known to be alive were invited to be resurveyed in middle-age.  Data were 
collected via a telephone interview in 1985 and medical examination one year later.  In the 
telephone interview, enquiries were made about the study participants’ health, health behaviours, 
and socio-economic characteristics (years of completed education, household income, and an index 
of occupational prestige32,33).  Smoking habits and marital status were ascertained using standard 
questions.  Study members were also asked about the existence of a range of physician-diagnosed 
health problems which included hypertension, cancer, diabetes, and coronary heart disease.34  The 
presence of one or more of these conditions was used to denote extant chronic disease.   
 
A random sample of telephone interview respondents (N=6443) was invited to attend a three day 
medical examination; 4462 did so (mean age 38.3 yr, SD 2.5).32,35,36  The same Army General 
Technical Test used at service entry was re-administered.  Additionally, following an overnight fast, 
blood was drawn, and blood pressure, lung function, resting heart rate, height and weight (to derive 
body mass index) were assessed using standard protocols.  Study participants were considered 
positive for depression, generalized anxiety disorder, and post-traumatic stress disorder if they 
reported a pattern of symptoms in the previous year that satisfied criteria from the Diagnostic and 
Statistical Manual of Mental Disorders (version III).29,37  The participants also reported their 
frequency of alcohol bingeing (defined as five or more ‘drinks’ on one occasion; a bottle/can beer, 
glass of wine, a cocktail, or measure of spirits constituted a drink).38   
 
Statistical analyses 
We used two approaches to quantify change in cognitive function.  In the first, employing a method 
common to epidemiology,39 change was computed by subtracting scores in early adulthood from 
those in middle-age.  In sensitivity analysis, we also show the results for another frequently used 
approach which involves additional adjustment of the change score for the baseline cognitive 
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function score in the regression models.  In the second approach, one more common to the field of 
psychology,40 we estimated the change in cognitive function by computing the residuals derived 
from regressing scores from the Army General Technical Test in middle-age on those obtained in 
early adulthood.  This method has the advantage of ensuring that the change score is orthogonal to 
the baseline test score.  With both methods yielding similar findings, we present the results from the 
first method in the paper and the other results in the supplementary tables (supplemental tables S1 
and S2).  
 
The relations between cognitive change and covariates with a continuous distribution were assessed 
by regressing the study covariates on the cognitive change score with adjustment for age at the time 
of the medical examination.  For dichotomous covariates, logistic regression was used to estimate 
odds ratios, 95% confidence intervals and p-values associated with change in cognitive function.  
These relationships are presented as the change in the covariates associated with a 10 unit increase 
in cognitive function (approximating to an increase of one half of a standard deviation in cognitive 
function). 
 
We examined the association between change in cognitive function and mortality by fitting this 
exposure in Cox proportional hazards regression models41 with follow-up time as the underlying 
time scale.  We estimated hazard ratios and accompanying 95% confidence intervals for mortality 
associated with a 10 unit increase in cognitive function.  In these analyses, we first adjusted for age, 
then ethnicity and army rank, and finally variables according to theme (behavioural, chronic 
disease, physiological, socioeconomic).  Follow-up time was taken from the date of the medical 
examination until censoring, death, or December 31st 2000 – whichever came first.  All analyses 





The final analytic sample comprised 4289 men with complete data.  In this group, the mean (SD) 
cognitive score in early adulthood (mean age 20.4; SD 1.7) was 106.1 (20.4).  At follow-up, after an 
average of eighteen years (mean age 37.9; 2.5), the overall mean cognitive score was 110.7 (21.8).  
Thus, 69% of the sample had an increase in performance whereby the mean improvement was 4.6 
(11.4) units.   
 
In table 1 we present the association of study covariates with change in cognitive function between 
early adulthood and middle-age.  Greater increases in cognitive function were evident in the 
younger men.  Taking these age effects into account, higher increases in cognitive function between 
early and later adulthood were associated with a more favourable risk factor profile.  Thus, a greater 
improvement in cognition was associated with lower levels of blood pressure, resting heart rate, and 
blood glucose.  Similarly, men whose cognitive function change between the two points of 
measurement was higher than their peers were less likely to subsequently be in poorer 
socioeconomic circumstances, to smoke, to drink alcohol, or experience generalised anxiety 
disorder.     
 
Table 2 depicts the association between change in cognitive function and later mortality risk.  A 
mean follow-up period of 14.6 years (SD 1.8) gave rise to 237 deaths from all-causes (including 62 
from cardiovascular disease, 47 from all cancers, and 51 from external causes).  In analyses in 
which hazard ratios were controlled for age, men with a greater increase in the cognitive score had a 
lower risk of mortality from all-causes and cardiovascular disease.  There was, however, essentially 
no apparent link between cognitive change and deaths from cancer of combined sites or deaths from 
injury.  Only small attenuations of these effect estimates were apparent after controlling for the 
behavioural, chronic disease, and physiological factors.  By contrast, adjustment for a range of 
indicators of socioeconomic status weakened these associations markedly, and statistical 
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significance at conventional levels was lost.  When all covariates were added together additional 
attenuation of the hazard ratios was apparent and results were again non-significant at conventional 
levels. 
 
We conducted two sets of sensitivity analyses.  In the first, in all models, the associations between 
cognitive change and mortality were additionally adjusted for baseline cognitive test scores 
(correlation coefficient between both measurements 0.85; p-value <0.001).  The results are shown 
in Supplementary table S1, and they are very similar to those in table 2.  In the second set of 
analyses, the cognitive changes scores were calculated by saving residuals from analyses that 
regressed scores from the second cognitive test on the first.  The results are shown in supplementary 
table S2, and, again, they are very similar to those in table 2. 
 
Discussion 
The main finding of this study was that men whose cognitive test scores increased more markedly 
from young adulthood to middle-age experienced a lower risk of total and cardiovascular disease 
mortality, though we found no discernible links with all cancers combined and external cause of 
death.  That adjusting for markers of socioeconomic position in adult life – education, income, 
occupational prestige – led to the greatest reduction in the strength of the relation between cognitive 
change and mortality ascribed to all-causes and cardiovascular disease points to a plausible 
mediation pathway: enhanced cognitive function might lead to educational success, and on to well 
remunerated, higher prestige employment, and it might be the latter which confers protection 
against premature mortality.  There are at least two alternative explanations.  First, adult socio-
economic position might serve as a proxy for cognitive change which itself has a direct effect on 
mortality risk.  Second, socio-economic position may have a cognition-enhancing impact via, for 
instance, occupational characteristics such as job complexity.  The present study is not able to 
distinguish between these explanations, however.    
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Study strengths and limitations 
This study is, to our knowledge, the first study to explore the health impact of change in cognition 
from late adolescence/early adulthood.  It is not without limitations, however.  First, this cohort 
solely comprises men and therefore the extent to which our results are transportable to women is 
unclear.   In general, the links between cognition function and death appear to be the same in men 
and women.  Second, the present analyses are largely based on a sample with complete information 
from a cognitive test, covariates at telephone interview and medical exam, and vital status 
(N=4289).  This group represents 67% of the random sub-sample invited to the medical 
examination, and 26% of persons originally enrolled in the study.  Although the latter is itself based 
on a random sample of surviving men, concerns are nonetheless raised about selection bias; that is, 
if the reported results differ markedly between persons included in the analyses and those not.  As 
previously shown,26 men in the excluded group had a marginally lower baseline cognitive function 
score than those in the analytical sample; however, there was generally little evidence of any 
systematic differences between the groups.  This was confirmed when we computed the relation 
between baseline cognitive test score and all-cause mortality in each of the groups for persons with 
the available data.  The strength of this association (hazard ratio for a 1 SD increase in cognition; 
95% confidence interval) was similar in men included (0.71; 0.63, 0.81) and excluded (0.79; 0.75, 
0.84) from the analyses (p-value for difference = 0.22).   
 
Third, the overall improvement in cognitive function in the present cohort could reflect 
development and/or familiarity with testing.  However, the analyses here use the individual 
differences in change, and the fact that there is an overall mean increase does not affect those.  
Fourth, if our measure of cognition, the Army General Technical Test, misclassified study 
members’ and this was not differential with respect to the outcome, our hazard ratios are likely to be 
underestimates for the true value.  Relatedly, using a longer, more detailed cognition battery on both 
assessment occasions would have resulted in less error and, again, effect estimates that were closer 
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to the true value.  Lastly, it would have been optimal to have data on inflammatory and hemostatic 
biomarkers, such as C-reactive protein, fibrinogen, and von Willebrand factor, which in their own 
right, or their correlates, have been linked to cognition42,43 and/or risk of death.44-46 
 
In conclusion, in the present study, we found an association of change in cognitive function 
between early adulthood and middle-age with mortality that was seemingly mediated via 
socioeconomic factors.  Further examination of this observation is justified, particularly in women 




1. Calvin CM, Deary IJ, Fenton C, et al. Intelligence in youth and all-cause-mortality: 
systematic review with meta-analysis. Int J Epidemiol 2011; 40: 626-44. 
2. Batty GD, Deary IJ, Zaninotto P. Association of Cognitive Function With Cause-Specific 
Mortality in Middle and Older Age: Follow-up of Participants in the English Longitudinal Study of 
Ageing. American journal of epidemiology 2016; 183(3): 183-90. 
3. Hayat SA, Luben R, Dalzell N, et al. Understanding the relationship between cognition and 
death: a within cohort examination of cognitive measures and mortality. European journal of 
epidemiology 2018; 33(11): 1049-62. 
4. Batty GD, Wennerstad KM, Smith GD, et al. IQ in early adulthood and mortality by middle 
age: cohort study of 1 million Swedish men. Epidemiology 2009; 20(1): 100-9. 
5. Cukic I, Brett CE, Calvin CM, Batty GD, Deary IJ. Childhood IQ and survival to 79: 
Follow-up of 94% of the Scottish Mental Survey 1947. Intelligence 2017; 63: 45-50. 
6. Batty GD, Mortensen EL, Nybo Andersen AM, Osler M. Childhood intelligence in relation 
to adult coronary heart disease and stroke risk: evidence from a Danish birth cohort study. 
Paediatric and perinatal epidemiology 2005; 19(6): 452-9. 
7. Twig G, Tirosh A, Derazne E, et al. Cognitive function in adolescence and the risk for 
premature diabetes and cardiovascular mortality in adulthood. Cardiovasc Diabetol 2018; 17(1): 
154. 
8. Modig Wennerstad K, Silventoinen K, Tynelius P, Bergman L, Rasmussen F. Association 
between intelligence and type-specific stroke: a population-based cohort study of early fatal and 
non-fatal stroke in one million Swedish men. J Epidemiol Community Health 2010; 64(10): 908-12. 
9. Calvin CM, Batty GD, Der G, et al. Childhood intelligence in relation to major causes of 
death in 68 year follow-up: prospective population study. BMJ (Clinical research ed) 2017; 357: 
j2708. 
10. Hagger-Johnson G, Deary IJ, Davies CA, Weiss A, Batty GD. Reaction time and mortality 
from the major causes of death: the NHANES-III study. PLoS One 2014; 9(1): e82959. 
11. Batty GD, Wennerstad KM, Smith GD, et al. IQ in early adulthood and later cancer risk: 
cohort study of one million Swedish men. Annals of oncology : official journal of the European 
Society for Medical Oncology 2007; 18(1): 21-8. 
12. Batty GD, Gale CR, Tynelius P, Deary IJ, Rasmussen F. IQ in early adulthood, 
socioeconomic position, and unintentional injury mortality by middle age: a cohort study of more 
than 1 million Swedish men. American journal of epidemiology 2009; 169(5): 606-15. 
13. Whitley E, Batty GD, Gale CR, Deary IJ, Tynelius P, Rasmussen F. Intelligence in early 
adulthood and subsequent risk of unintentional injury over two decades: cohort study of 1 109 475 
Swedish men. J Epidemiol Community Health 2010; 64(5): 419-25. 
14. Whitley E, Batty GD, Gale CR, Deary IJ, Tynelius P, Rasmussen F. Intelligence in early 
adulthood and subsequent risk of assault: cohort study of 1,120,998 Swedish men. Psychosomatic 
medicine 2010; 72(4): 390-6. 
15. Batty GD, Whitley E, Deary IJ, Gale CR, Tynelius P, Rasmussen F. Psychosis alters 
association between IQ and future risk of attempted suicide: cohort study of 1,109,475 Swedish 
men. BMJ (Clinical research ed) 2010; 340: c2506. 
16. Batty GD, Shipley MJ, Kivimaki M, Smith GD, West R. Impact of smoking cessation 
advice on future smoking behavior, morbidity, and mortality: up to 40 years of follow-up of the first 
randomized controlled trial of a general population sample. Arch Intern Med 2011; 171(21): 1950-
1. 
17. Plassman BL, Williams JW, Jr., Burke JR, Holsinger T, Benjamin S. Systematic review: 
factors associated with risk for and possible prevention of cognitive decline in later life. Ann Intern 
Med 2010; 153(3): 182-93. 
 13 
18. Halonen JI, Lallukka T, Pentti J, et al. Change in Job Strain as a Predictor of Change in 
Insomnia Symptoms: Analyzing Observational Data as a Non-randomized Pseudo-Trial. Sleep 
2017; 40(1). 
19. Virtanen M, Vahtera J, Singh-Manoux A, Elovainio M, Ferrie JE, Kivimaki M. Unfavorable 
and favorable changes in modifiable risk factors and incidence of coronary heart disease: The 
Whitehall II cohort study. International journal of cardiology 2018; 269: 7-12. 
20. White J, Greene G, Kivimaki M, Batty GD. Association between changes in lifestyle and 
all-cause mortality: the Health and Lifestyle Survey. J Epidemiol Community Health 2018; 72(8): 
711-4. 
21. White J, Kivimaki M, Batty GD. Changes in Health Behaviors and Longevity. 
Epidemiology 2018; 29(4): e26-e7. 
22. Clarke R, Shipley M, Lewington S, et al. Underestimation of risk associations due to 
regression dilution in long-term follow-up of prospective studies. American journal of epidemiology 
1999; 150(4): 341-53. 
23. White J, Zaninotto P, Walters K, et al. Duration of depressive symptoms and mortality risk: 
the English Longitudinal Study of Ageing (ELSA). The British journal of psychiatry : the journal of 
mental science 2016; 208(4): 337-42. 
24. Karr JE, Graham RB, Hofer SM, Muniz-Terrera G. When does cognitive decline begin? A 
systematic review of change point studies on accelerated decline in cognitive and neurological 
outcomes preceding mild cognitive impairment, dementia, and death. Psychology and aging 2018; 
33(2): 195-218. 
25. Shipley BA, Der G, Taylor MD, Deary IJ. Association between mortality and cognitive 
change over 7 years in a large representative sample of UK residents. PsychosomMed 2007; 69(7): 
640-50. 
26. Batty GD, Shipley MJ, Mortensen LH, et al. IQ in late adolescence/early adulthood, risk 
factors in middle age and later all-cause mortality in men: the Vietnam Experience Study. J 
Epidemiol Community Health 2008; 62(6): 522-31. 
27. Health status of Vietnam veterans. III. Reproductive outcomes and child health. The Centers 
for Disease Control Vietnam Experience Study. Jama 1988; 259(18): 2715-9. 
28. Health status of Vietnam veterans. II. Physical Health. The Centers for Disease Control 
Vietnam Experience Study. Jama 1988; 259(18): 2708-14. 
29. Health status of Vietnam veterans. I. Psychosocial characteristics. The Centers for Disease 
Control Vietnam Experience Study. Jama 1988; 259(18): 2701-7. 
30. Postservice mortality among Vietnam veterans. The Centers for Disease Control Vietnam 
Experience Study. Jama 1987; 257(6): 790-5. 
31. Wechsler D. Manual of the Wechsler Adult Intelligence Scale. New York: Psychological 
Corporation. 
32. Batty GD, Shipley MJ, Dundas R, et al. Does IQ explain socio-economic differentials in 
total and cardiovascular disease mortality? Comparison with the explanatory power of traditional 
cardiovascular disease risk factors in the Vietnam Experience Study. Eur Heart J 2009; 30(15): 
1903-9. 
33. Batty GD, Shipley MJ, Gale CR, Mortensen LH, Deary IJ. Does IQ predict total and 
cardiovascular disease mortality as strongly as other risk factors? Comparison of effect estimates 
using the Vietnam Experience Study. Heart 2008; 94(12): 1541-4. 
34. Phillips AC, Carroll D, Gale CR, Lord JM, Arlt W, Batty GD. Cortisol, DHEAS, their ratio 
and the metabolic syndrome: evidence from the Vietnam Experience Study. Eur J Endocrinol 2010; 
162(5): 919-23. 
35. Batty GD, Gale CR, Mortensen LH, Langenberg C, Shipley MJ, Deary IJ. Pre-morbid 
intelligence, the metabolic syndrome and mortality: the Vietnam Experience Study. Diabetologia 
2008; 51(3): 436-43. 
36. Batty GD, Mortensen LH, Shipley MJ. Semen quality and risk factors for mortality. 
Epidemiology 2019. 
 14 
37. Gale CR, Deary IJ, Boyle SH, Barefoot J, Mortensen LH, Batty GD. Cognitive ability in 
early adulthood and risk of 5 specific psychiatric disorders in middle age: the Vietnam experience 
study. Arch Gen Psychiatry 2008; 65(12): 1410-8. 
38. Mortensen LH, Sorensen TI, Gronbaek M. Intelligence in relation to later beverage 
preference and alcohol intake. Addiction 2005; 100(10): 1445-52. 
39. Lee CG, Boyko EJ, Nielson CM, et al. Mortality risk in older men associated with changes 
in weight, lean mass, and fat mass. J Am Geriatr Soc 2011; 59(2): 233-40. 
40. Shipley BA, Der G, Taylor MD, Deary IJ. Association between mortality and cognitive 
change over 7 years in a large representative sample of UK residents. Psychosomatic medicine 
2007; 69(7): 640-50. 
41. Cox DR. Regression models and life-tables. J R Stat Soc [Ser B] 1972; 34: 187-220. 
42. Calvin CM, Batty GD, Lowe GD, Deary IJ. Childhood intelligence and midlife 
inflammatory and hemostatic biomarkers: the National Child Development Study (1958) cohort. 
Health psychology : official journal of the Division of Health Psychology, American Psychological 
Association 2011; 30(6): 710-8. 
43. Phillips AC, Batty GD, van Zanten JJ, et al. Cognitive ability in early adulthood is 
associated with systemic inflammation in middle age: the Vietnam experience study. Brain Behav 
Immun 2011; 25(2): 298-301. 
44. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, 
albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. 
Jama 1998; 279(18): 1477-82. 
45. Danesh J, Erqou S, Walker M, et al. The Emerging Risk Factors Collaboration: analysis of 
individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 
prospective studies of cardiovascular diseases. European journal of epidemiology 2007; 22(12): 
839-69. 
46. Kaptoge S, Di Angelantonio E, Lowe G, et al. C-reactive protein concentration and risk of 
coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 











 Table 1.  Association of a 10 unit increase in cognitive function between early adulthood  
and middle-age with risk factors for mortality in middle-age (N=4289) 
 
 Absolute difference in risk factor 
 (95% confidence interval) 
P-value 
   
Age at medical examination (yr) -0.28 (-0.35, -0.22) <0.001 
Forced expiratory volume in one second (l) 0.02 (0.00, 0.04) 0.034 
Total cholesterol (mmol/l) 0.01 (-0.01, 0.04) 0.34 
High density lipoprotein cholesterol (mmol/l) -0.01 (-0.02, 0.00) 0.029 
Systolic blood pressure (mmHg) -0.5 (-0.9, -0.2) <0.001 
Diastolic blood pressure (mmHg) -0.5 (-0.8, -0.3) <0.001 
Pulse rate (beats/min) -0.5 (-0.9, -0.2) <0.001 
Blood glucose (mg/dl) -0.5b (-0.8, -0.1) 0.008 
Body mass index (kg/m2) 0.1 (0.0, 0.2) 0.25 
Height (m) 0.002 (0.000, 0.004) 0.046 
   
 Odds ratios (95% confidence interval)  
Non-white ethnicity   0.86 (0.81, 0.92) <0.001 
Not married  0.85 (0.80, 0.90) <0.001 
Low occupational prestige   0.86 (0.80, 0.92) <0.001 
Low income  0.85 (0.80, 0.90) <0.001 
Low education 0.89 (0.82, 0.96) 0.003 
Current smoker  0.97 (0.92, 1.02) 0.28 
Current alcohol drinker 0.88 (0.83, 0.94) <0.001 
Binge drinker (among current drinkers) 0.93 (0.87, 0.99) 0.017 
Generalised anxiety disorder  0.89 (0.82, 0.98) 0.012 
Post-traumatic stress disorder 1.05 (0.95, 1.17) 0.33 
Depression  0.94 (0.85, 1.04) 0.24 
Somatic disease  0.97 (0.90, 1.05) 0.51 
   
 
a Effect estimates from linear regression and logistic regression analyses are adjusted for age, except age.  
b Blood glucose effect shown as a percentage change since distribution skewed. Median blood glucose is 92 mg/dl. 
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Table 2.  Hazard ratio (95% confidence interval) for the association of a 10 unit increase in cognitive function  
between early adulthood and middle-age with selected causes of mortality (N=4289) 
 
Adjustment 
 All causes 
(237 deaths)  
CVD 
(62 deaths)  
All cancers 
(47 deaths)  
Injury 
(51 deaths) 
         
Age     0.84 (0.75, 0.93)  0.78 (0.64, 0.95)  1.14 (0.88, 1.47)  0.96 (0.76, 1.22) 
Age + army rank, ethnicity  0.87 (0.79, 0.97)  0.82 (0.67, 0.99)  1.14 (0.89, 1.46)  0.96 (0.76, 1.22) 
Age + behavioural factorsa  0.85 (0.77, 0.95)  0.79 (0.65, 0.96)  1.13 (0.88, 1.46)  0.97 (0.76, 1.23) 
Age + chronic disease factorsb  0.85 (0.77, 0.95)  0.79 (0.65, 0.97)  1.14 (0.89, 1.47)  0.97 (0.76, 1.23) 
Age + physiological factorsc  0.88 (0.79, 0.98)  0.81 (0.66, 0.98)  1.17 (0.91, 1.51)  0.97 (0.77, 1.23) 
Age + socioeconomic factorsd  0.91 (0.82, 1.00)  0.84 (0.69, 1.02)  1.13 (0.88, 1.46)  1.02 (0.81, 1.28) 
All above covariates  0.94 (0.85, 1.04)  0.86 (0.71, 1.06)  1.14 (0.89, 1.47)  1.02 (0.81, 1.29) 
         
   
  CVD, cardiovascular disease 
a Behavioural factors are: smoking habit, alcohol consumption 
b Chronic disease factors are:  somatic disease, psychiatric factors (depression, post traumatic stress disorder, anxiety)  
c Physiological factors are: systolic blood pressure, diastolic blood pressure, pulse rate, blood glucose, FEV1, BMI, cholesterol 
d Socioeconomic factors are: marital status, occupational prestige, education, family income 
